Clinical trials allow us to help patients of today and tomorrow. We currently have 12 active clinical trials, with 1 actively recruiting patients. This page will be updated as new studies are opened. If you do not see a study for the condition you are searching for, feel free to reach out to us at 855-554-6374 or recruitment@menterderm.com
RECRUITING STUDIES
ASLAN004-003: A randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial to evaluate the efficacy and safety of ASLAN004 in adult patients with moderate-to-severe atopic dermatitis.
Clinical trial for adults (age > 18) with at least a 6-month history of atopic dermatitis. In terms of severity, the trial requires a BSA involvement of >10% (and a minimum EASI score of 16). A subset of patients with prior dupixent exposure will be permitted to enter the study.
Study length: 16 weeks.
BSA is determined by measuring the number of handprints of involvement present. A handprint includes the palm and the fingers as shown in the image. 1-handprint is approximately equivalent to 1% of body surface area. In other words, if a study requires 10% – this will equate to 10-handprints.
ANB019-401: An international, multicenter, prospective registry of patients with generalized pustular psoriasis (GPP).
Clinical trial for adults (age > 18) with clinically confirmed diagnosis of GPP.
Study length: 24 months.
OTHER ACTIVE STUDIES
(No-longer Enrolling Patients)
Abbvie M15-997
UCB PS0015
BMS IM011075
Arcutis ARC-154-309